Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 Article

fiu authors

publication date

  • April 1, 2009

keywords

  • 1p/19q loss of heterozygosity
  • CHROMOSOME ARMS 1P
  • Clinical Neurology
  • EUROPEAN-ORGANIZATION
  • GLIOBLASTOMA
  • Oncology
  • PROCARBAZINE
  • RADIOTHERAPY
  • SURVIVAL
  • Science & Technology
  • oligodendroglioma

Digital Object Identifier (DOI)

end page

  • 175

issue

  • 2